{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MD simulations", "VEGFR-2", "anticancer", "apoptosis", "cell cycle analysis", "docking", "gene expression", "isatin derivatives", "quinoline derivatives"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35975321", "DateCompleted": {"Year": "2022", "Month": "08", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2022.2110869"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "37", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies.", "Pagination": {"StartPage": "2191", "EndPage": "2205", "MedlinePgn": "2191-2205"}, "Abstract": {"AbstractText": ["New quinoline and isatin derivatives having the main characteristics of VEGFR-2 inhibitors was synthesised. The antiproliferative effects of these compounds were estimated against A549, Caco-2, HepG2, and MDA-MB-231. Compounds <b>13</b> and <b>14</b> showed comparable activities with doxorubicin against the Caco-2 cells. These compounds strongly inhibited VEGFR-2 kinase activity. The cytotoxic activities were evaluated against Vero cells. Compound <b>7</b> showed the highest value of safety and selectivity. Cell migration assay displayed the ability of compound <b>7</b> to prevent healing and migration abilities in the cancer cells. Furthermore, compound <b>7</b> induced apoptosis in Caco-2 through the expressive down-regulation of the apoptotic genes, Bcl2, Bcl-xl, and Survivin, and the upregulation of the TGF gene. Molecular docking against VEGFR-2 emerged the interactions of the synthesised compounds in a similar way to sorafenib. Additionally, seven molecular dynamics simulations studies were applied and confirmed the stability of compound <b>13</b> in the active pocket of VEGFR-2 over 100\u2009ns."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Taghour", "ForeName": "Mohammed S", "Initials": "MS"}, {"Identifier": ["0000-0002-6620-241X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Mahdy", "ForeName": "Hazem A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt."}], "LastName": "Eldehna", "ForeName": "Wagdy M", "Initials": "WM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}, {"Identifier": [], "Affiliation": "Pharmaceutical and Fermentation Industries Development Center, City of Scientific Research and Technological Applications (SRTA city), Alexandria, Egypt."}], "LastName": "El-Deeb", "ForeName": "Nehal M", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nucleic Acids Research Department, Genetic Engineering and Biotechnology Research Institute. City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}], "LastName": "Kenawy", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia."}], "LastName": "A Alsfouk", "ForeName": "Bshra", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Dahab", "ForeName": "Mohammed A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}, {"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "El-Zahabi", "ForeName": "Mohamed A", "Initials": "MA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolines"}, {"RegistryNumber": "82X95S7M06", "NameOfSubstance": "Isatin"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Vascular Endothelial Growth Factor Receptor-2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Caco-2 Cells"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Isatin"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quinolines"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Vascular Endothelial Growth Factor Receptor-2"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO Cancer . Key facts. https://www.who.int/news-room/fact-sheets/detail/cancer [last accessed 26 Jan 2022]."}, {"Citation": "NHS Cancer . Overview. https://www.nhs.uk/conditions/cancer/ [last accessed 27 Jan 2022]."}, {"Citation": "Wong MC, Huang J, Lok V, et al. . Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol 2021;19:955\u201366. e61.", "ArticleIdList": ["32088300"]}, {"Citation": "Bray F, Ferlay J, Soerjomataram I, et al. . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394\u2013424.", "ArticleIdList": ["30207593"]}, {"Citation": "Meier P, Finch A, Evan G.. Apoptosis in development. Nature 2000;407:796\u2013801.", "ArticleIdList": ["11048731"]}, {"Citation": "Lowe SW, Lin AW.. Apoptosis in cancer. Carcinogenesis 2000;21:485\u201395.", "ArticleIdList": ["10688869"]}, {"Citation": "Fernald K, Kurokawa M.. Evading apoptosis in cancer. Trends Cell Biol 2013;23:620\u201333.", "ArticleIdList": ["PMC4091735", "23958396"]}, {"Citation": "Farghaly TA, Al-Hasani WA, Abdulwahab HG.. An updated patent review of VEGFR-2 inhibitors (2017-present). Exp Opin Ther Pat 2021;31:989\u20131007. (just-accepted).", "ArticleIdList": ["34043477"]}, {"Citation": "Li Y, Zhang F, Nagai N, et al. . VEGF-B inhibits apoptosis via VEGFR-1\u2013mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest 2008;118:913\u201323.", "ArticleIdList": ["PMC2230661", "18259607"]}, {"Citation": "Xiao X, Wu J, Zhu X, et al. . Induction of cell cycle arrest and apoptosis in human nasopharyngeal carcinoma cells by ZD6474, an inhibitor of VEGFR tyrosine kinase with additional activity against EGFR tyrosine kinase. Int J Cancer 2007;121:2095\u2013104.", "ArticleIdList": ["17631646"]}, {"Citation": "Otrock ZK, Mahfouz RA, Makarem JA, Shamseddine AI.. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol Dis 2007;39:212\u201320.", "ArticleIdList": ["17553709"]}, {"Citation": "Ferrara N, Gerber H-P, LeCouter J.. The biology of VEGF and its receptors. Nat Med 2003;9:669\u201376.", "ArticleIdList": ["12778165"]}, {"Citation": "Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368\u201380.", "ArticleIdList": ["12409337"]}, {"Citation": "Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L.. VEGF-receptor signal transduction. Trends Biochem Sci 2003;28:488\u201394.", "ArticleIdList": ["13678960"]}, {"Citation": "Marrone TJ, Briggs a, James M, McCammon JA.. Structure-based drug design: computational advances. Annu Rev Pharmacol Toxicol 1997;37:71\u201390.", "ArticleIdList": ["9131247"]}, {"Citation": "Li N, Wang Y, Li W, et al. . Screening of some sulfonamide and sulfonylurea derivatives as anti-Alzheimer\u2019s agents targeting BACE1 and PPAR\u03b3. J Chem 2020;2020:1\u201319."}, {"Citation": "Abdel-Aziz HA, Eldehna WM, Fares M, et al. . Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents. Int J Mol Sci 2015;16:8719\u201343.", "ArticleIdList": ["PMC4425105", "25903147"]}, {"Citation": "Parmar DR, Soni JY, Guduru R, et al. . Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in\u00a0vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg Chem 2021;115:105206.", "ArticleIdList": ["34339975"]}, {"Citation": "Eissa IH, Ibrahim MK, Metwaly AM, et al. . Design, molecular docking, in\u00a0vitro, and in\u00a0vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorg Chem. 2021;107:104532.", "ArticleIdList": ["33334586"]}, {"Citation": "Alanazi MM, Eissa IH, Alsaif NA, et al. . Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J Enzyme Inhib Med Chem 2021;36:1760\u201382.", "ArticleIdList": ["PMC8344243", "34340610"]}, {"Citation": "El-Metwally SA, Abou-El-Regal MM, Eissa IH, et al. . Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorg Chem 2021;112:104947.", "ArticleIdList": ["33964580"]}, {"Citation": "Lee K, Jeong K-W, Lee Y, et al. . Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors. Eur J Med Chem 2010;45:5420\u20137.", "ArticleIdList": ["20869793"]}, {"Citation": "Machado VA, Peixoto D, Costa R, et al. . Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno [3, 2-b] pyridin-7-ylthio) phenyl] ureas: discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors. Bioorg Med Chem 2015;23:6497\u2013509.", "ArticleIdList": ["26344591"]}, {"Citation": "Dietrich J, Hulme C, Hurley LH.. The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec\u00ae, Nexavar\u00ae, and BIRB-796. Bioorg Med Chem 2010;18:5738\u201348.", "ArticleIdList": ["20621496"]}, {"Citation": "Viegas-Junior C, Danuello A, da Silva Bolzani V, et al. . Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 2007;14:1829\u201352.", "ArticleIdList": ["17627520"]}, {"Citation": "Meth-Cohn O, Narine B, Tarnowski B.. A versatile new synthesis of quinolines and related fused pyridines, Part 5. The synthesis of 2-chloroquinoline-3-carbaldehydes. J Chem Soc Perkin Trans 1 1981;1520\u201330."}, {"Citation": "Kar K, Krithika U, Basu P, et al. . Design, synthesis and glucose uptake activity of some novel glitazones. Bioorg Chem 2014;56:27\u201333.", "ArticleIdList": ["24927033"]}, {"Citation": "Shih M-H, Yeh M-Y.. Access to the syntheses of sydnonyl-substituted \u03b1, \u03b2-unsaturated ketones and 1, 3-dihydro-indol-2-ones by modified Knoevenagel reaction. Tetrahedron 2003;59:4103\u201311."}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55\u201363.", "ArticleIdList": ["6606682"]}, {"Citation": "Denizot F, Lang R.. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271\u20137.", "ArticleIdList": ["3486233"]}, {"Citation": "Thabrew M, Hughes RD, Mcfarlane IG.. Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. J Pharm Pharmacol 2011;49:1132\u20135.", "ArticleIdList": ["9401951"]}, {"Citation": "Pritchett JC, Naesens L, Montoya J.. Treating HHV-6 infections: the laboratory efficacy and clinical use of anti-HHV-6 agents. In: Flamand L, Lautenschlager I, Krueger G, Ablashi D, ed. Human herpesviruses HHV-6A, HHV-6B & HHV-7. 3rd ed. Amsterdam, Netherlands: Elsevier; 2014."}, {"Citation": "Pe\u00f1a-Mor\u00e1n OA, Villarreal ML, \u00c1lvarez-Berber L, et al. . Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines. Molecules. 2016;21:1013.", "ArticleIdList": ["PMC6274026", "27527135"]}, {"Citation": "Indrayanto G, Putra GS, Suhud F.. Excipients, R. Methodology, Validation of in-vitro bioassay methods: application in herbal drug research. Profiles Drug Subst Excip Relat Methodol. 2021;46:273\u2013307.", "ArticleIdList": ["33461699"]}, {"Citation": "Liang C-C, Park AY, Guan J-L.. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in\u00a0vitro. Nat Protocols 2007;2:329\u201333.", "ArticleIdList": ["17406593"]}, {"Citation": "Kim R. Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochem Biophys Res Commun 2005;333:336\u201343.", "ArticleIdList": ["15922292"]}, {"Citation": "Yang J, Song K, Krebs TL, et al. . Rb/E2F4 and Smad2/3\u2009link survivin to TGF-\u03b2-induced apoptosis and tumor progression. Oncogene 2008;27:5326\u201338.", "ArticleIdList": ["PMC2762862", "18504435"]}, {"Citation": "Liu Y, Gray NS.. Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol 2006;2:358\u201364.", "ArticleIdList": ["16783341"]}, {"Citation": "Sousa SF, Fernandes PA, Ramos MJ.. Protein\u2013ligand docking: current status and future challenges. Proteins 2006;65:15\u201326.", "ArticleIdList": ["16862531"]}, {"Citation": "Hollingsworth SA, Dror RO.. Molecular dynamics simulation for all. Neuron 2018;99:1129\u201343.", "ArticleIdList": ["PMC6209097", "30236283"]}, {"Citation": "Hansson T, Oostenbrink C, van Gunsteren W.. Molecular dynamics simulations. Current Opin Struct Biol 2002;12:190\u20136.", "ArticleIdList": ["11959496"]}, {"Citation": "Durrant JD, McCammon JA.. Molecular dynamics simulations and drug discovery. BMC Biol 2011;9:71\u20139.", "ArticleIdList": ["PMC3203851", "22035460"]}, {"Citation": "Kuzmanic A, Zagrovic B.. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys J 2010;98:861\u201371.", "ArticleIdList": ["PMC2830444", "20197040"]}, {"Citation": "Liu P, Lu J, Yu H, et al. . Lubricant shear thinning behavior correlated with variation of radius of gyration via molecular dynamics simulations. J Chem Phys 2017;147:084904.", "ArticleIdList": ["28863549"]}, {"Citation": "Kumar K, Anbarasu A, Ramaiah S.. Molecular docking and molecular dynamics studies on \u03b2-lactamases and penicillin binding proteins. Mol BioSyst 2014;10:891\u2013900.", "ArticleIdList": ["24503740"]}, {"Citation": "El-Deeb NM, Ibrahim OM, Mohamed MA, et al. . Alginate/\u03ba-carrageenan oral microcapsules loaded with Agaricus bisporus polysaccharides MH751906 for natural killer cells mediated colon cancer immunotherapy. Int J Biol Macromol 2022;205:385\u201395.", "ArticleIdList": ["35183600"]}, {"Citation": "Abou-Seri SM, Eldehna WM, Ali MM, Abou El Ella DA.. 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: synthesis and in\u00a0vitro biological evaluation. Eur J Med Chem 2016;107:165\u201379.", "ArticleIdList": ["26590508"]}, {"Citation": "Borenfreund E, Puerner JA.. Toxicity determined in\u00a0vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985;24:119\u201324.", "ArticleIdList": ["3983963"]}, {"Citation": "Koch A, Tamez P, Pezzuto J, Soejarto D.. Evaluation of plants used for antimalarial treatment by the Maasai of Kenya. J Ethnopharmacol 2005;101:95\u20139.", "ArticleIdList": ["15878245"]}, {"Citation": "Arranz-Valsero I, Soriano-Roman\u00ed L, Garc\u00eda-Posadas L, et al. . IL-6 as a corneal wound healing mediator in an in\u00a0vitro scratch assay. Exp Eye Res 2014;125:183\u201392.", "ArticleIdList": ["24971496"]}, {"Citation": "Zucchini N, de Sousa G, Bailly-Maitre B, et al. . Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochim Biophys Acta Mol Cell Res 2005;1745:48\u201358.", "ArticleIdList": ["16085054"]}, {"Citation": "Ibrahim MK, Eissa IH, Abdallah AE, et al. . Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR\u03b3 and SUR agonists. Biorg Med Chem 2017;25:1496\u2013513.", "ArticleIdList": ["28117121"]}, {"Citation": "Suleimen YM, Jose RA, Suleimen RN, et al. . Jusanin, a new flavonoid from artemisia commutata with an in silico inhibitory potential against the SARS-CoV-2 main protease. Molecules 2022;27:1636.", "ArticleIdList": ["PMC8911936", "35268738"]}, {"Citation": "Mohammed SO, El Ashry ESH, Khalid A, et al. . Expression, purification, and comparative inhibition of helicobacter pylori urease by regio-selectively alkylated benzimidazole 2-thione derivatives. Molecules 2022;27:865.", "ArticleIdList": ["PMC8838460", "35164122"]}, {"Citation": "Jo S, Kim T, Iyer VG, Im W.. CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 2008;29:1859\u201365.", "ArticleIdList": ["18351591"]}, {"Citation": "Brooks BR, Brooks CL, III, Mackerell AD, Jr, et al. . CHARMM: the biomolecular simulation program. J Comput Chem 2009;30:1545\u2013614.", "ArticleIdList": ["PMC2810661", "19444816"]}, {"Citation": "Lee J, Cheng X, Swails JM, et al. . CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J Chem Theor Comput 2016;12:405\u201313.", "ArticleIdList": ["PMC4712441", "26631602"]}, {"Citation": "Best RB, Zhu X, Shim J, et al. . Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J Chem Theor Comput 2012;8:3257\u201373.", "ArticleIdList": ["PMC3549273", "23341755"]}, {"Citation": "Phillips JC, Braun R, Wang W, et al. . Scalable molecular dynamics with NAMD. J Comput Chem 2005;26:1781\u2013802.", "ArticleIdList": ["PMC2486339", "16222654"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "17", "Hour": "2", "Minute": "23"}, {"Year": "2022", "Month": "8", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "16"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35975321", "PMC9387325", "10.1080/14756366.2022.2110869"]}}], "PubmedBookArticle": []}